Home › Calculator › CHJTF Dividend Calculator 2026
CHJTF Dividend DRIP Calculator 2026
3.79% YieldHealthcareCSPC Pharmaceutical Group Limited · OTC
Price: $0.98 · Annual div: $0.04/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CHJTF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CHJTF snowball 📈
$10,000 in CHJTF → $1108.88M in 10 years · $87,793,768.77/month
About CSPC Pharmaceutical Group Limited (CHJTF) — Dividend Analysis 2026
CSPC Pharmaceutical Group Limited operates as an investment holding company with a core focus on the research, development, manufacturing, and global commercialization of pharmaceutical products. Its extensive operations span the People's Republic of China, other Asian markets, the Americas, Europe, and various international territories. The company segments its business into Finished Drugs, Bulk Products, and Functional Food and Others. Within its diverse portfolio of finished drug products, CSPC addresses a wide array of medical conditions. Notable offerings include NBP soft capsules and injections for acute ischemic stroke, Oulaining capsules and injections designed for mild to moderate memory and mental impairment, and Enxi to manage adult idiopathic Parkinson's disease. In the oncology sector, the company provides treatments like Duomeisu for lymphomas, multiple myeloma, ovarian, and breast cancers, alongside other malignant tumors, as well as Keaili specifically for breast cancer. Additionally, Jinyouli helps prevent leucopenia and infection induced by chemotherapy. Furthermore, CSPC's product range extends to various anti-infectives, such as Shuluoke, Nuomoling, Weihong, and Xinweihong. Cardiovascular health is targeted with Xuanning for hypertension and Encun, aimed at preventing atherosclerotic thrombosis events. For metabolic disorders, Linmeixin and Shuanglexin assist in diabetes management, while Gubang and Gubangjia treat osteoporosis in postmenopausal women. The company also offers solutions for pain and inflammation, including Qixiao for upper respiratory tract infections and Gaoshunsong, which provides relief for numerous musculoskeletal and inflammatory conditions such like different forms of arthritis, frozen shoulder, bursitis, tenosynovitis, acute gout, dysmenorrhea, toothache, postoperative pain, low back pain, sprains, strains, and other soft tissue injuries. Beyond these, CSPC's therapeutic offerings feature Debixin for various ulcer conditions and Qimaite for both acute and chronic pain management. The company is also a producer of active pharmaceutical ingredients (APIs), including antibiotics, vitamin C, and caffeine, in addition to manufacturing functional food items and glucose products, and providing healthcare services. Initially incorporated in 1992 as China Pharmaceutical Group Limited, the company underwent a rebranding in March 2013 to become CSPC Pharmaceutical Group Limited. Its corporate headquarters are located in Shijiazhuang, People's Republic of China.
Compare CHJTF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CHJTF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CHJTF position with:
🌍 CHJTF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CHJTF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3.79% | 0.99% | $379 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 3.22% | 0.42% | $322 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 3.03% | 0.23% | $303 / yr |
| 🇬🇧 UK ISA | 0% | 3.79% | 0.99% | $379 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3.46% | 0.66% | $346 / yr |
| 🇨🇦 TFSA | 0% | 3.79% | 0.99% | $379 / yr |
| 🇨🇦 CA Taxable | 25% | 2.84% | 0.04% | $284 / yr |
| 🇦🇺 Super (pension) | 15% | 3.22% | 0.42% | $322 / yr |
| 🇦🇺 AU Taxable | 30% | 2.65% | -0.15% | $265 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.79% | -0.01% | $279 / yr |
| 🇫🇷 FR Taxable | 30% | 2.65% | -0.15% | $265 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CHJTF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.04/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CHJTF Dividend Payment Schedule
CHJTF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 CHJTF vs Healthcare Benchmarks
How CHJTF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CHJTF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CHJTF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CHJTF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
CSPC Pharmaceutical Group Limited (CHJTF) is currently trading at $0.98, 31% below its 52-week high. The current dividend yield is 3.79% based on an annual payout of $0.04 per share.
CHJTF (CSPC Pharmaceutical Group Limited) — 3.79% Dividend Yield Analysis
CSPC Pharmaceutical Group Limited (CHJTF) is a healthcare stock currently trading at $0.98 with a dividend yield of 3.79%. The company pays an annual dividend of $0.04 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, CHJTF has grown its dividend at a compound annual rate of 98.0%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.